fidelis glp 1 coverage GLP-1 in Employer Plans Could Nearly Double in 2024 GLP-1 coverage for obesity treatment

A study linking statins, the microbiome, and blood sugar control doesnt change clinical practice

Maintaining weight loss after stopping a medication like GLP-1 can be challenging, but with the righ

Over time, some patients may need to pause or stop therapy due to side effects, plateaus, or changing goals

Recientemente, destacados expertos en diabetes publicaron una nueva declaracin de consenso sobre el uso seguro y eficaz de los medicamentos GLP-1/GIP para la diabetes tipo 1.

Discover how combining GLP-1 medications with structured wellness programs can reinforce weight loss management and enhance employee wellbeing.

Endocrinology Teams Top Recommendation